What Is Hindsight Bias In Investing?
You’ve probably heard the expression “hindsight is 20/20.” That saying…
Sell
11
ADAP Quote, Financials, Valuation and Earnings
Last price:
$0.25
Seasonality move
:
23.87%
Day range:
$0.25 - $0.29
52-week range:
$0.25 - $1.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.36x
P/B ratio:
5.43x
Volume:
3.1M
Avg. volume:
1.8M
1-year change:
-82.64%
Market cap:
$64.3M
Revenue:
$178M
EPS (TTM):
-$0.31
Earnings Data
Next earnings date for ADAP
May 15
2025
Most recent earnings per share
-$0.31
Missed by $0.16
(Mar 20/2025)
Consensus Estimate
-$0.15
(Mar 20/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ADAP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/15/2025 | Q1 | $6.7M | -- | -- | -$0.17 | -- |
| 03/20/2025 | Q4 | $8.2M | $3.2M | -$0.31 | -$0.15 | -$0.16 |
| 11/13/2024 | Q3 | $20.5M | $40.9M | -$0.06 | -$0.18 | $0.12 |
| 08/12/2024 | Q2 | $44.8M | $128.2M | $0.24 | -$0.20 | $0.44 |
| 05/15/2024 | Q1 | $20.5M | $5.7M | -$0.18 | -$0.20 | $0.02 |
| 03/06/2024 | Q4 | $26M | $231K | -$0.18 | -$0.17 | -$0.01 |
| 11/08/2023 | Q3 | -- | -- | -$0.18 | -$0.17 | -$0.01 |
| 08/09/2023 | Q2 | -- | -- | -$0.12 | -$0.18 | $0.06 |
| 05/12/2023 | Q1 | -- | -- | $0.01 | -$0.16 | $0.16 |
| 03/06/2023 | Q4 | -- | -- | -$0.18 | -$0.25 | $0.07 |
| 11/08/2022 | Q3 | -- | -- | -$0.24 | -$0.27 | $0.03 |
| 08/04/2022 | Q2 | -- | -- | -$0.30 | -$0.27 | -$0.03 |
| 05/09/2022 | Q1 | -- | -- | -$0.30 | -$0.26 | -$0.04 |
| 03/14/2022 | Q4 | -- | -- | -$0.24 | -- | -- |
| 11/04/2021 | Q3 | -- | -- | -$0.30 | -$0.27 | -$0.04 |
| 08/09/2021 | Q2 | -- | -- | -$0.24 | -$0.24 | $0.00 |
| 05/06/2021 | Q1 | -- | -- | -$0.24 | -$0.25 | $0.01 |
| 02/25/2021 | Q4 | -- | -- | -$0.24 | -- | -- |
| 11/05/2020 | Q3 | -- | -- | -$0.24 | -- | -- |
| 08/06/2020 | Q2 | -- | -- | -$0.24 | -- | -- |
| 05/14/2020 | Q1 | -- | -- | -$0.24 | -- | -- |
| 02/27/2020 | Q4 | -- | -- | -$0.30 | -- | -- |
| 11/06/2019 | Q3 | -- | -- | -$0.36 | -- | -- |
| 08/01/2019 | Q2 | -- | -- | -$0.42 | -- | -- |
| 05/06/2019 | Q1 | -- | -- | -$0.24 | -- | -- |
| 02/27/2019 | Q4 | -- | -- | -$0.36 | -- | -- |
| 11/06/2018 | Q3 | -- | -- | $0.06 | -- | -- |
| 08/02/2018 | Q2 | -- | -- | -$0.48 | -- | -- |
| 05/09/2018 | Q1 | -- | -- | -$0.24 | -- | -- |
| 03/15/2018 | Q4 | -- | -- | -$0.30 | -- | -- |
| 11/02/2017 | Q3 | -- | -- | -$0.01 | -- | -- |
| 08/03/2017 | Q2 | -- | -- | -$0.24 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.30 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.24 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$0.30 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.24 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$0.02 | -- | -- |
Adaptimmune Therapeutics PLC Earnings Questions
-
How Much did Adaptimmune Therapeutics PLC Generate in Revenue Last Quarter?
Adaptimmune Therapeutics PLC reported $3.2M worth of top line sales in its most recent quarter.
-
Did Adaptimmune Therapeutics PLC Beat Earnings Last Quarter?
Adaptimmune Therapeutics PLC announced earnings per share of -$0.31 which represents a miss of analyst forecast a -$0.15 per share.
-
Is Adaptimmune Therapeutics PLC Profitable?
Adaptimmune Therapeutics PLC reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Adaptimmune Therapeutics PLC EPS Next Year?
Adaptimmune Therapeutics PLC's earnings are forecast to decrease from -$0.30 per share to -$0.14 per share next year representing a decrease of -63%.
-
When is Adaptimmune Therapeutics PLC's Earnings Date?
Adaptimmune Therapeutics PLC's next earnings date is May 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Rivian a Good Stock a Buy?
Rivian Automotive (RIVN) had an initial IPO of close to…
Will Chevron Acquire Hess?
Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
47
RGC alert for Mar 26
Regencell Bioscience Holdings [RGC] is up 4.9% over the past day.
Sell
39
W alert for Mar 26
Wayfair [W] is up 2.01% over the past day.
Sell
46
TSLA alert for Mar 26
Tesla [TSLA] is up 3.5% over the past day.
